MODERATOR(S)
Caitlin Schonewolf, MD, MS - Natera
Speaker(s)
Nancy Lee, MD, FASTRO - Memorial Sloan Kettering Cancer Center
Paul Romesser, MD - Memorial Sloan Kettering Cancer Center
session DESCRIPTION
As a growing body of clinical evidence continues to validate SignateraTM tumor-informed MRD testing across lung, gastrointestinal, and head and neck cancers, clinicians are increasingly leveraging ctDNA data to make more informed, individualized treatment decisions. This industry expert theater will feature a distinguished panel of radiation oncology experts to examine where the science stands today and how MRD testing can be integrated into radiation oncology practice.
Livestream: https://projection.zoom.us/j/84835296454?pwd=t3ZGHM6LC2iSyBux52Ig4F86yoY8by.1